Miguel Coego Rios
Director of Finance/CFO presso CENTOGENE N.V.
Profilo
Jose Miguel Coego Rios is currently the Chief Financial Officer, Legal, IT & MD at Centogene NV.
Previously, he held the position of Chief Financial Officer-EMEA & Vice President at Mundipharma International Ltd.
He also served as the Chief Financial Officer-LATAM & GM-Andrea Region at Shire Plc from 2011 to 2019.
Additionally, he worked as the Vice President & General Manager-South Europe at Orphazyme A.
Posizioni attive di Miguel Coego Rios
| Società | Posizione | Inizio |
|---|---|---|
| CENTOGENE N.V. | Director of Finance/CFO | 31/03/2022 |
Precedenti posizioni note di Miguel Coego Rios
| Società | Posizione | Fine |
|---|---|---|
| SHIRE | Corporate Officer/Principal | 01/01/2019 |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
| ORPHAZYME A/S | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ORPHAZYME A/S | Health Technology |
| CENTOGENE N.V. | Commercial Services |
| Aziende private | 2 |
|---|---|
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Miguel Coego Rios
